Neurocrine Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NBIX for the last quarter is 515.30 M USD, and it's 0.02% higher compared to the previous quarter. The net income of Q1 24 is 43.40 M USD.